BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11250764)

  • 1. Multiple endocrine neoplasia type iia: report of a family with a study of three generations in qatar.
    Zirie M; Mohammed I; El-Emadi M; Haider A
    Endocr Pract; 2001; 7(1):19-27. PubMed ID: 11250764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 2A. Study of a family.
    Correia MJ; Lopes LO; Bugalho MJ; Cristina L; Santos AI; Bordalo AD; Pinho B; da Silva HL; Gonçalves MD; Ribeiro C; Tuna JL
    Rev Port Cardiol; 2000 Jan; 19(1):11-31. PubMed ID: 10731788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
    Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and genetic screening of an extended family with MEN2A.
    Algün E; Abaci N; Kösem M; Kotan C; Köseoğlu B; Boztepe H; Sekeroğlu R; Aslan H; Topal C; Ayakta H; Uygan I; Alagöl F; Erginel-Unaltuna N; Aksoy H
    J Endocrinol Invest; 2002; 25(7):603-8. PubMed ID: 12150334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.
    González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M
    Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
    Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.
    Zwolak A; Rudzki G; Świrska J; Dudzińska M; Daniluk J; Tarach J
    Endokrynol Pol; 2015; 66(5):462-8. PubMed ID: 26457501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
    Moers AM; Landsvater RM; Schaap C; Jansen-Schillhorn van Veen JM; de Valk IA; Blijham GH; Höppener JW; Vroom TM; van Amstel HK; Lips CJ
    Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.
    Yamashita T; Lihara M; Okamoto J; Kanbe M; Ito Y; Kawakami M; Egawa S; Yamaguchi K; Obara T
    Jpn J Clin Oncol; 1997 Feb; 27(1):42-5. PubMed ID: 9070340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families.
    Marsh DJ; McDowall D; Hyland VJ; Andrew SD; Schnitzler M; Gaskin EL; Nevell DF; Diamond T; Delbridge L; Clifton-Bligh P; Robinson BG
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):213-20. PubMed ID: 8849577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy.
    Siggelkow H; Melzer A; Nolte W; Karsten K; Hoppner W; Hufner M
    Eur J Endocrinol; 2001 May; 144(5):467-73. PubMed ID: 11331212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study.
    Nguyen L; Niccoli-Sire P; Caron P; Bastie D; Maes B; Chabrier G; Chabre O; Rohmer V; Lecomte P; Henry JF; Conte-Devolx B;
    Eur J Endocrinol; 2001 Jan; 144(1):37-44. PubMed ID: 11174835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of multiple endocrine neoplasia type 2A (MEN2A) with a mutation in the RET gene].
    Ishizu K; Shiraishi K; Kawamura H; Naito K; Takahashi T; Yoshimura K; Tangoku A; Shirahama S
    Hinyokika Kiyo; 1999 Jun; 45(6):407-10. PubMed ID: 10442282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.
    Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N
    World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.